Llusern raises €900K Seed round
10 October 2024· Cardiff, United Kingdom· health, biotech, b2b, b2g, software_hardware
The funding is intended to help the company commercialize its point-of-care testing for Urinary Tract Infections (UTIs) and take its Lodestar DX platform to market.
Investors
LeadDevelopment Bank of Wales
Also participating
EKF Diagnostics
About Llusern
Stage
Seed
Headquarters
Cardiff, United Kingdom
Founded
2020
Team Size
6–20
Sectors
healthbiotechb2bb2gsoftware_hardware